Several EU countries could scupper plans by the European commission to approve the relicensing of a weedkiller linked to cancer. The vote to relicense glyphosate, a key ingredient in herbicides such as Monsanto's multibillion-dollar brand Roundup, had been scheduled at a two-day meeting of experts from the EU's 28 member states, which begins on Monday. But officials are now saying that they may postpone the vote rather than lose it, raising the prospect of a legal limbo for glyphosate, the licence for which runs out in June. France, the Netherlands and Sweden have all said they will not support an assessment by the European food safety authority (Efsa) that glyphosate is harmless. That ruling ran counter to findings by the WHO's cancer agency that glyphosate was probably carcinogenic to humans", causing a bitter row over scientific methodology and industry influence. The Swedish environment minister, sa Romson, said: "We won't take risks with glyphosate and we don't think that the analysis done so far is good enough. We will propose that no decision is taken until further analysis has been done and the Efsa scientists have been more transparent about their considerations." An Efsa panel based its recommendation that glyphosate was safe ... on six industry-funded studies that have not been fully published. Glyphosate use has been banned or restricted in large parts of Europe because of alleged links to a host of health problems, ranging from birth defects and kidney failure to coeliac disease, colitis and autism.